ASND
$227.87+0.25%
as of close, Oct 2, 2026
☾ AH $227.87 +0.25%
Ascendis Pharma A/S Ordinary ShareStock · Health CareNasdaq Composite 0.03%Russell 1000 0.02%Russell 3000 0.02%
ASND SEC filings (2026)
CIK 1612042 · Pharmaceutical Preparations (SIC 2834) · incorporated in G7 · fiscal year ends in December
792 filings on EDGAR since 2014 · 12 annual, 0 quarterly, 429 current · financial statements · earnings
Latest 20-F
Feb 11, 2026
fiscal year to Dec 31, 2025
Latest 8-K
Sep 29, 2026
current report
Filings on file
792
since 2014, 140 insider forms
What happened, last 12 months#
Every earnings release with its print, every report with its quarter, the other 8-Ks by what they covered, the proxy statements, and each day an insider bought or sold — newest first, each line opening the filing on EDGAR. The index by form and year follows.
September 2026
- Sep 298-K8-K · Report of a foreign private issuer
- Sep 158-K8-K · Report of a foreign private issuer
- Sep 158-K8-K · Report of a foreign private issuer
- Sep 98-K8-K · Report of a foreign private issuer
- Sep 98-K8-K · Report of a foreign private issuer
- Sep 8Insider saleBodenhoff Mads (SVP & PAO) sold 3,000 shares for $811K at $270.19
- Sep 2Insider saleHOLTUG LARS (Director) sold 236 shares for $62K at $264.13
August 2026
- Aug 318-K8-K · Report of a foreign private issuer
- Aug 14Insider buyBIENAIME JEAN JACQUES (Director) bought 2,000 shares for $493K at $245.85–$246.91
- Aug 138-K8-K · Report of a foreign private issuer
- Aug 138-K8-K · Report of a foreign private issuer
- Aug 128-K8-K · Report of a foreign private issuer
- Aug 68-K8-K · Report of a foreign private issuer
July 2026
- Jul 158-K8-K · Report of a foreign private issuer
June 2026
- Jun 308-K8-K · Report of a foreign private issuer
- Jun 298-K8-K · Report of a foreign private issuer
- Jun 178-K8-K · Report of a foreign private issuer
- Jun 158-K8-K · Report of a foreign private issuer
- Jun 128-K8-K · Report of a foreign private issuer
- Jun 108-K8-K · Report of a foreign private issuer
- Jun 2Insider buySMITH SCOTT THOMAS (EVP & Chief Financial Officer) bought 100 shares for $22K at $219.00
May 2026
- May 29Insider buyBIENAIME JEAN JACQUES (Director) bought 500 shares for $112K at $222.30–$223.76
- May 29Insider buySMITH SCOTT THOMAS (EVP & Chief Financial Officer) bought 250 shares for $56K at $223.32
- May 26Insider buyBIENAIME JEAN JACQUES (Director) bought 400 shares for $95K at $236.24–$239.37
- May 138-K8-K · Report of a foreign private issuer
- May 11Insider saleJENSEN FLEMMING STEEN (See Remarks) sold 19,460 shares for $4.6M at $238.49
- May 78-K8-K · Report of a foreign private issuer
- May 78-K8-K · Report of a foreign private issuer
April 2026
- Apr 218-K8-K · Report of a foreign private issuer
- Apr 218-K8-K · Report of a foreign private issuer
- Apr 208-K8-K · Report of a foreign private issuer
- Apr 168-K8-K · Report of a foreign private issuer
- Apr 88-K8-K · Report of a foreign private issuer
- Apr 88-K8-K · Report of a foreign private issuer
- Apr 78-K8-K · Report of a foreign private issuer
March 2026
- Mar 308-K8-K · Report of a foreign private issuer
- Mar 248-K8-K · Report of a foreign private issuer
- Mar 178-K8-K · Report of a foreign private issuer
- Mar 168-K8-K · Report of a foreign private issuer
- Mar 118-K8-K · Report of a foreign private issuer
- Mar 28-K8-K · Report of a foreign private issuer
February 2026
- Feb 238-K8-K · Report of a foreign private issuer
- Feb 11ReportAnnual report (foreign private issuer), FY2025 — revenue $814.8M (+107% y/y), net income −$258.0M, EPS −$4.25
- Feb 118-K8-K · Report of a foreign private issuer
- Feb 118-K8-K · Report of a foreign private issuer
January 2026
- Jan 148-K8-K · Report of a foreign private issuer
- Jan 128-K8-K · Report of a foreign private issuer
- Jan 98-K8-K · Report of a foreign private issuer
December 2025
- Dec 308-K8-K · Report of a foreign private issuer
- Dec 108-K8-K · Report of a foreign private issuer
November 2025
- Nov 268-K8-K · Report of a foreign private issuer
- Nov 128-K8-K · Report of a foreign private issuer
- Nov 128-K8-K · Report of a foreign private issuer
- Nov 128-K8-K · Report of a foreign private issuer
October 2025
- Oct 228-K8-K · Report of a foreign private issuer
- Oct 158-K8-K · Report of a foreign private issuer
- Oct 88-K8-K · Report of a foreign private issuer
Insider transactions#
What officers, directors and 10% holders reported on Forms 4 and 5 over the last 13 months, from the documents themselves: one insider’s trades of one kind on one day are one row, with the shares, the price range and the total as filed. Open-market buys and sells first; awards, exercises, tax withholding, gifts and employee-plan purchases are grouped below them.
Over the last 13 months insiders sold $5.5M in 3 sales and bought $777K in 5 purchases; 4 other transactions (awards, exercises, tax withholding, gifts and plan purchases).
| Date | Insider |
|---|---|
| Sep 8, 2026Form 4 | Bodenhoff MadsSVP & PAOSold · $811K · 3,000 sh |
| Sep 2, 2026Form 4 | HOLTUG LARSDirectorSold · $62K · 236 sh |
| Aug 14, 2026Form 4 | BIENAIME JEAN JACQUESDirectorBought · $493K · 2,000 sh |
| Jun 2, 2026Form 4 | SMITH SCOTT THOMASEVP & Chief Financial OfficerBought · $22K · 100 sh |
| May 29, 2026Form 4 | BIENAIME JEAN JACQUESDirectorBought · $112K · 500 sh |
| May 29, 2026Form 4 | SMITH SCOTT THOMASEVP & Chief Financial OfficerBought · $56K · 250 sh |
| May 26, 2026Form 4 | BIENAIME JEAN JACQUESDirectorBought · $95K · 400 sh |
| May 11, 2026Form 4 | JENSEN FLEMMING STEENSee RemarksSold · $4.6M · 19,460 sh |
Awards, exercises, withholding and plan purchases · 4 transactions
| Date | Insider |
|---|---|
| Sep 8, 2026Form 4 | Bodenhoff MadsSVP & PAOExercise or conversion · $330K · 3,000 sh |
| Sep 8, 2026Form 4 | Bodenhoff MadsSVP & PAOExercise or conversion · Warrants · $0 · 3,000 sh |
| Apr 14, 2026Form 4 | BIENAIME JEAN JACQUESDirectorOther · Warrants · — · 9,160 sh |
| Apr 14, 2026Form 4 | BIENAIME JEAN JACQUESDirectorAward · Warrants · — · 9,160 sh |
Reports and proxy statements#
Annual reports (10-K, 20-F, 40-F), quarterly reports (10-Q), current reports (8-K, 6-K) and proxy statements, newest first. An 8-K is described by its items. A form opens the document on EDGAR, or the filing’s index where it furnishes exhibits (an earnings release is the 8-K’s Exhibit 99.1).
2026 · 40 filings
| Filed | What it is |
|---|---|
| Sep 29, 20266-K | Report of a foreign private issuer |
| Sep 15, 20266-K | Report of a foreign private issuer |
| Sep 15, 20266-K | Report of a foreign private issuer |
| Sep 9, 20266-K | Report of a foreign private issuer |
| Sep 9, 20266-K | Report of a foreign private issuer |
| Aug 31, 20266-K | Report of a foreign private issuer |
| Aug 13, 20266-K | Report of a foreign private issuer |
| Aug 13, 20266-K | Report of a foreign private issuer |
| Aug 12, 20266-K | Report of a foreign private issuer |
| Aug 6, 20266-K | Report of a foreign private issuer |
| Jul 15, 20266-K | Report of a foreign private issuer |
| Jun 30, 20266-K | Report of a foreign private issuer |
| Jun 29, 20266-K | Report of a foreign private issuer |
| Jun 17, 20266-K | Report of a foreign private issuer |
| Jun 15, 20266-K | Report of a foreign private issuer |
| Jun 12, 20266-K | Report of a foreign private issuer |
| Jun 10, 20266-K | Report of a foreign private issuer |
| May 13, 20266-K | Report of a foreign private issuer |
| May 7, 20266-K | Report of a foreign private issuer |
| May 7, 20266-K | Report of a foreign private issuer |
| Apr 21, 20266-K | Report of a foreign private issuer |
| Apr 21, 20266-K | Report of a foreign private issuer |
| Apr 20, 20266-K | Report of a foreign private issuer |
| Apr 16, 20266-K | Report of a foreign private issuer |
| Apr 8, 20266-K | Report of a foreign private issuer |
| Apr 8, 20266-K | Report of a foreign private issuer |
| Apr 7, 20266-K | Report of a foreign private issuer |
| Mar 30, 20266-K | Report of a foreign private issuer |
| Mar 24, 20266-K | Report of a foreign private issuer |
| Mar 17, 20266-K | Report of a foreign private issuer |
| Mar 16, 20266-K | Report of a foreign private issuer |
| Mar 11, 20266-K | Report of a foreign private issuer |
| Mar 2, 20266-K | Report of a foreign private issuer |
| Feb 23, 20266-K | Report of a foreign private issuer |
| Feb 11, 20266-K | Report of a foreign private issuer |
| Feb 11, 202620-F | Annual report (foreign private issuer), FY2025 — revenue $814.8M (+107% y/y), net income −$258.0M, EPS −$4.25 |
| Feb 11, 20266-K | Report of a foreign private issuer |
| Jan 14, 20266-K | Report of a foreign private issuer |
| Jan 12, 20266-K | Report of a foreign private issuer |
| Jan 9, 20266-K | Report of a foreign private issuer |
2025 · 38 filings
| Filed | What it is |
|---|---|
| Dec 30, 20256-K | Report of a foreign private issuer |
| Dec 10, 20256-K | Report of a foreign private issuer |
| Nov 26, 20256-K | Report of a foreign private issuer |
| Nov 12, 20256-K | Report of a foreign private issuer |
| Nov 12, 20256-K | Report of a foreign private issuer |
| Nov 12, 20256-K | Report of a foreign private issuer |
| Oct 22, 20256-K | Report of a foreign private issuer |
| Oct 15, 20256-K | Report of a foreign private issuer |
| Oct 8, 20256-K | Report of a foreign private issuer |
| Sep 30, 20256-K | Report of a foreign private issuer |
| Sep 10, 20256-K | Report of a foreign private issuer |
| Aug 13, 20256-K | Report of a foreign private issuer |
| Aug 7, 20256-K | Report of a foreign private issuer |
| Aug 7, 20256-K | Report of a foreign private issuer |
| Jul 28, 20256-K | Report of a foreign private issuer |
| Jul 9, 20256-K | Report of a foreign private issuer |
| Jun 27, 20256-K | Report of a foreign private issuer |
| Jun 11, 20256-K | Report of a foreign private issuer |
| Jun 9, 20256-K | Report of a foreign private issuer |
| Jun 9, 20256-K | Report of a foreign private issuer |
| Jun 2, 20256-K | Report of a foreign private issuer |
| May 28, 20256-K | Report of a foreign private issuer |
| May 14, 20256-K | Report of a foreign private issuer |
| May 1, 20256-K | Report of a foreign private issuer |
| May 1, 20256-K | Report of a foreign private issuer |
| Apr 29, 20256-K | Report of a foreign private issuer |
| Apr 9, 20256-K | Report of a foreign private issuer |
| Mar 31, 20256-K | Report of a foreign private issuer |
| Mar 28, 20256-K | Report of a foreign private issuer |
| Mar 20, 20256-K | Report of a foreign private issuer |
| Mar 12, 20256-K | Report of a foreign private issuer |
| Feb 12, 202520-F | Annual report (foreign private issuer), FY2024 — revenue $393.5M (+36% y/y), net income −$409.1M, EPS −$7.07 |
| Feb 12, 20256-K | Report of a foreign private issuer |
| Feb 12, 20256-K | Report of a foreign private issuer |
| Feb 12, 20256-K | Report of a foreign private issuer |
| Jan 15, 20256-K | Report of a foreign private issuer |
| Jan 13, 20256-K | Report of a foreign private issuer |
| Jan 13, 20256-K | Report of a foreign private issuer |
2024 · 44 filings
| Filed | What it is |
|---|---|
| Dec 30, 20246-K | Report of a foreign private issuer |
| Dec 17, 20246-K | Report of a foreign private issuer |
| Dec 12, 20246-K | Report of a foreign private issuer |
| Dec 11, 20246-K | Report of a foreign private issuer |
| Nov 14, 20246-K | Report of a foreign private issuer |
| Nov 14, 20246-K | Report of a foreign private issuer |
| Nov 13, 20246-K | Report of a foreign private issuer |
| Nov 4, 20246-K | Report of a foreign private issuer |
| Oct 9, 20246-K | Report of a foreign private issuer |
| Sep 30, 20246-K | Report of a foreign private issuer |
| Sep 27, 20246-K | Report of a foreign private issuer |
| Sep 23, 20246-K | Report of a foreign private issuer |
| Sep 16, 20246-K | Report of a foreign private issuer |
| Sep 16, 20246-K | Report of a foreign private issuer |
| Sep 12, 20246-K | Report of a foreign private issuer |
| Sep 11, 20246-K | Report of a foreign private issuer |
| Sep 3, 20246-K | Report of a foreign private issuer |
| Sep 3, 20246-K | Report of a foreign private issuer |
| Sep 3, 20246-K | Report of a foreign private issuer |
| Aug 14, 20246-K | Report of a foreign private issuer |
| Aug 12, 20246-K | Report of a foreign private issuer |
| Jul 10, 20246-K | Report of a foreign private issuer |
| Jun 28, 20246-K | Report of a foreign private issuer |
| Jun 12, 20246-K | Report of a foreign private issuer |
| May 31, 20246-K | Report of a foreign private issuer |
| May 16, 20246-K | Report of a foreign private issuer |
| May 14, 20246-K | Report of a foreign private issuer |
| May 2, 20246-K | Report of a foreign private issuer |
| May 2, 20246-K | Report of a foreign private issuer |
| May 2, 20246-K | Report of a foreign private issuer |
| Apr 24, 20246-K | Report of a foreign private issuer |
| Apr 10, 20246-K | Report of a foreign private issuer |
| Mar 27, 20246-K | Report of a foreign private issuer |
| Mar 14, 20246-K | Report of a foreign private issuer |
| Feb 29, 20246-K | Report of a foreign private issuer |
| Feb 14, 20246-K | Report of a foreign private issuer |
| Feb 7, 202420-F | Annual report (foreign private issuer), FY2023 — revenue $288.5M (+436% y/y), net income −$520.7M, EPS −$9.25 |
| Feb 7, 20246-K | Report of a foreign private issuer |
| Jan 31, 20246-K | Report of a foreign private issuer |
| Jan 29, 20246-K | Report of a foreign private issuer |
| Jan 10, 20246-K | Report of a foreign private issuer |
| Jan 8, 20246-K | Report of a foreign private issuer |
| Jan 8, 20246-K | Report of a foreign private issuer |
| Jan 2, 20246-K | Report of a foreign private issuer |
2023 · 47 filings — 46 × 6-K, 1 × 20-F
2022 · 43 filings — 42 × 6-K, 1 × 20-F
2021 · 43 filings — 42 × 6-K, 1 × 20-F
2020 · 39 filings — 38 × 6-K, 1 × 20-F
2019 · 35 filings — 34 × 6-K, 1 × 20-F
2018 · 34 filings — 33 × 6-K, 1 × 20-F
2017 · 35 filings — 34 × 6-K, 1 × 20-F
2016 · 21 filings — 20 × 6-K, 1 × 20-F
Counted, not listed; the year is on EDGAR.
2015 · 22 filings — 20 × 6-K, 1 × 20-F, 1 × 6-K/A
Counted, not listed; the year is on EDGAR.
Insider, ownership and other filings#
Insider ownership (Forms 3, 4, 5 and 144), beneficial ownership (Schedules 13D and 13G), registration and prospectus (S-1, S-3, S-8, 424B and related) and the rest, counted by year, with the newest 25 of each of the latest 3 years shown. A Form 4 is one insider’s transaction report; a 13G is a passive holder above five percent.
2026 · 59 filings — 22 × 144, 15 × 3, 9 × 4 and 7 other forms
| Filed | What it is |
|---|---|
| Sep 28, 20264 | Insider transaction (Form 4) |
| Sep 9, 20264 | Insider transaction (Form 4) |
| Sep 8, 2026144 | Notice of proposed sale (Form 144) |
| Sep 3, 20264 | Insider transaction (Form 4) |
| Sep 2, 2026144 | Notice of proposed sale (Form 144) |
| Aug 18, 20264 | Insider transaction (Form 4) |
| Aug 13, 2026SCHEDULE 13G/A | Other filings |
| Jun 2, 20264 | Insider transaction (Form 4) |
| Jun 1, 20264 | Insider transaction (Form 4) |
| Jun 1, 20264 | Insider transaction (Form 4) |
| Jun 1, 20263/A | Initial insider holdings (Form 3), amended |
| May 27, 20264 | Insider transaction (Form 4) |
| May 22, 2026SD | Specialized disclosure (conflict minerals) |
| May 15, 2026SCHEDULE 13G/A | Other filings |
| May 14, 2026SCHEDULE 13G/A | Other filings |
| May 12, 20264 | Insider transaction (Form 4) |
| May 11, 2026144 | Notice of proposed sale (Form 144) |
| May 7, 2026SCHEDULE 13G/A | Other filings |
| May 7, 2026SCHEDULE 13G | Other filings |
| May 6, 2026SCHEDULE 13G/A | Other filings |
| Apr 20, 20268-A12B/A | Exchange listing registration, amended |
| Apr 1, 20263 | Initial insider holdings (Form 3) |
| Mar 18, 20263 | Initial insider holdings (Form 3) |
| Mar 18, 20263 | Initial insider holdings (Form 3) |
| Mar 18, 20263 | Initial insider holdings (Form 3) |
The newest 25 of 59 shown; the full year is on EDGAR.
2025 · 56 filings — 43 × 144, 9 × SCHEDULE 13G/A, 2 × SCHEDULE 13G and 2 other forms
| Filed | What it is |
|---|---|
| Dec 4, 2025144 | Notice of proposed sale (Form 144) |
| Dec 2, 2025144 | Notice of proposed sale (Form 144) |
| Dec 2, 2025144 | Notice of proposed sale (Form 144) |
| Dec 2, 2025144 | Notice of proposed sale (Form 144) |
| Dec 1, 2025144 | Notice of proposed sale (Form 144) |
| Nov 14, 2025SCHEDULE 13G/A | Other filings |
| Nov 14, 2025SCHEDULE 13G/A | Other filings |
| Sep 9, 2025144 | Notice of proposed sale (Form 144) |
| Aug 29, 2025144 | Notice of proposed sale (Form 144) |
| Aug 27, 2025144 | Notice of proposed sale (Form 144) |
| Aug 20, 2025144 | Notice of proposed sale (Form 144) |
| Aug 15, 2025144 | Notice of proposed sale (Form 144) |
| Aug 14, 2025144 | Notice of proposed sale (Form 144) |
| Aug 14, 2025SCHEDULE 13G/A | Other filings |
| Aug 14, 2025SCHEDULE 13G/A | Other filings |
| Aug 13, 2025144 | Notice of proposed sale (Form 144) |
| Aug 13, 2025144 | Notice of proposed sale (Form 144) |
| Aug 13, 2025SCHEDULE 13G | Other filings |
| Aug 12, 2025144 | Notice of proposed sale (Form 144) |
| May 14, 2025SD | Specialized disclosure (conflict minerals) |
| May 14, 2025SCHEDULE 13G/A | Other filings |
| May 14, 2025SCHEDULE 13G | Other filings |
| May 12, 2025144 | Notice of proposed sale (Form 144) |
| May 12, 2025SCHEDULE 13G/A | Other filings |
| May 7, 2025144 | Notice of proposed sale (Form 144) |
The newest 25 of 56 shown; the full year is on EDGAR.
2024 · 55 filings — 32 × 144, 16 × SC 13G/A, 2 × 424B5 and 4 other forms
| Filed | What it is |
|---|---|
| Dec 10, 2024144 | Notice of proposed sale (Form 144) |
| Dec 10, 2024144 | Notice of proposed sale (Form 144) |
| Dec 10, 2024144 | Notice of proposed sale (Form 144) |
| Dec 10, 2024144 | Notice of proposed sale (Form 144) |
| Dec 10, 2024144 | Notice of proposed sale (Form 144) |
| Dec 10, 2024144 | Notice of proposed sale (Form 144) |
| Dec 10, 2024144 | Notice of proposed sale (Form 144) |
| Dec 3, 2024144 | Notice of proposed sale (Form 144) |
| Nov 19, 2024144 | Notice of proposed sale (Form 144) |
| Nov 14, 2024SC 13G/A | Passive holder above 5% (Schedule 13G), amended |
| Nov 14, 2024SC 13G/A | Passive holder above 5% (Schedule 13G), amended |
| Nov 14, 2024SC 13G/A | Passive holder above 5% (Schedule 13G), amended |
| Nov 14, 2024SC 13G/A | Passive holder above 5% (Schedule 13G), amended |
| Nov 12, 2024SC 13G/A | Passive holder above 5% (Schedule 13G), amended |
| Nov 8, 2024SC 13G/A | Passive holder above 5% (Schedule 13G), amended |
| Sep 20, 2024424B5 | Prospectus supplement |
| Sep 18, 2024424B5 | Prospectus supplement |
| Sep 18, 2024F-3ASR | Registration and prospectus |
| Sep 4, 2024S-8 | Employee stock plan registration |
| May 29, 2024SD | Specialized disclosure (conflict minerals) |
| Mar 7, 2024144 | Notice of proposed sale (Form 144) |
| Mar 5, 2024144 | Notice of proposed sale (Form 144) |
| Mar 5, 2024144 | Notice of proposed sale (Form 144) |
| Mar 5, 2024144 | Notice of proposed sale (Form 144) |
| Mar 5, 2024144 | Notice of proposed sale (Form 144) |
The newest 25 of 55 shown; the full year is on EDGAR.
2023 · 28 filings — 15 × 144, 8 × SC 13G/A, 2 × SC 13G and 3 other forms
Counted, not listed; the year is on EDGAR.
2022 · 8 filings — 7 × SC 13G/A, 1 × SD
Counted, not listed; the year is on EDGAR.
2021 · 13 filings — 6 × SC 13G/A, 2 × 424B5, 2 × S-8 and 2 other forms
Counted, not listed; the year is on EDGAR.
2020 · 13 filings — 6 × SC 13G/A, 3 × SC 13D/A, 2 × 424B5 and 2 other forms
Counted, not listed; the year is on EDGAR.
2019 · 16 filings — 6 × SC 13G/A, 5 × SC 13D/A, 3 × 424B5 and 2 other forms
Counted, not listed; the year is on EDGAR.
2018 · 17 filings — 4 × SC 13D/A, 2 × 424B5, 2 × SC 13G and 7 other forms
Counted, not listed; the year is on EDGAR.
2017 · 22 filings — 5 × CORRESP, 5 × SC 13G/A, 3 × 424B5 and 6 other forms
Counted, not listed; the year is on EDGAR.
2016 · 28 filings — 8 × SC 13D/A, 4 × S-8, 4 × SC 13G/A and 6 other forms
Counted, not listed; the year is on EDGAR.
2015 · 26 filings — 4 × CORRESP, 4 × SC 13D, 2 × EFFECT and 13 other forms
Counted, not listed; the year is on EDGAR.
2014 · 10 filings — 3 × UPLOAD, 2 × DRS/A, 2 × DRSLTR and 3 other forms
Counted, not listed; the year is on EDGAR.
About this data
Ascendis Pharma A/S Ordinary Share (ASND) has 792 filings on EDGAR going back to 2014: 12 annual reports, 0 quarterly reports and 429 current reports, plus proxy statements, insider forms and ownership schedules. Its latest annual report, a 20-F, was filed on Feb 11, 2026 for the fiscal year ended Dec 31, 2025. The most recent 8-K, on Sep 29, 2026, covered a material event. Over the last 13 months insiders sold $5.5M in 3 sales and bought $777K in 5 purchases; 4 other transactions (awards, exercises, tax withholding, gifts and plan purchases). Not investment advice.
Every row is a filing EDGAR lists for the registrants that have been Ascendis Pharma A/S Ordinary Share, read from the SEC’s submissions index each morning; a filing accepted after that read appears the next day. Where a company changed its filing entity (a holding-company reorganisation, Google into Alphabet) the predecessor’s filings are shown for the years it filed as the company, derived from the filings themselves. Dates are the filing date; the period is the report’s own. The latest 3 years of reports are listed in full, the next years to 10 without their 8-Ks, and older years are counted; the other forms are counted too, with the newest 25 of each of the latest 3 years shown. Insider transactions are the Form 4 and Form 5 documents themselves, filed since January 2026, every number as the insider filed it: a day’s lots are summed, a blank price adds its shares and no dollars, and a purchase through an employee stock plan is a plan purchase, not insider buying. The documents stay on sec.gov, public domain, and every link opens the SEC’s copy. ChartRow does not summarise or interpret filings.
FAQ#
- Where can I read ASND's latest 10-K?
- ASND's latest annual report, a 20-F, was filed on Feb 11, 2026 for the fiscal year ended Dec 31, 2025. It is linked above and opens on EDGAR, the SEC's own site, where every exhibit is also listed.
- When did ASND last file an 8-K?
- On Sep 29, 2026: a current report. An 8-K reports a material event between quarterly reports; the one that furnishes the quarter's results is filed under Item 2.02.
- Are ASND insiders buying or selling?
- Over the last 13 months insiders sold $5.5M in 3 sales and bought $777K in 5 purchases; 4 other transactions (awards, exercises, tax withholding, gifts and plan purchases). The most recent sale: Bodenhoff Mads (SVP & PAO) sold 3,000 shares on Sep 8, 2026 for $811K. Every figure is as the insider filed it on Form 4; a sale under a 10b5-1 plan was scheduled in advance.
- How many SEC filings has ASND made?
- 792 filings are on EDGAR under the registrant records that have been Ascendis Pharma A/S Ordinary Share, going back to 2014; 140 of them are insider ownership forms (Forms 3, 4, 5 and 144).